LAS VEGAS, NV — (Marketwired) — 11/21/16 — (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), a development stage bio-tech company focused on the commercialization and development of microcurrent therapeutic devices that promote general wellness and alleviate complications associated with medical conditions including, but not limited to, diabetes, Parkinson–s disease, high blood pressure, is pleased to announce that it has appointed Gregory Pek to the Company
LAS VEGAS, NV — (Marketwired) — 07/13/16 — (OTCQB: CMXC) ("Cell MedX" or the "Company"), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes, is pleased to provide its shareholders with an update on its observational clinical trial carried out by Nutrasource Diagnostics Inc. ("NDI") as well as its research and development of the eBalance Devices.Further to the news release the Com
LAS VEGAS, NV — (Marketwired) — 03/22/16 — (OTCQB: CMXC), ("Cell MedX" or the "Company") is pleased to announce that it has engaged Nutrasource Diagnostics Inc. ("NDI") to commence clinical trials of its innovative and proprietary technology branded under the trade name eBalance. The intent of the upcoming trial is to assess and quantify eBalance–s ability to alter key metabolic pathways targeting improved blood sugar control. The trial will be conducted at se
Startup Founded by Mother of a Child Recently Diagnosed With Type 1 Diabetes Uses Kickstarter Campaign and Feedback From Diabetes Community to Launch App; Beta Version to Be Showcased at the 2015 Children with Diabetes Friends for Life Conference
LAS VEGAS, NV — (Marketwired) — 02/25/15 — Cell MedX Corp. (OTCQB: CMXC) (the "Company") is pleased to announce that it has received the first results of the analysis of metabolomic assays taken during the Phase 1 pilot clinical trial.The pilot clinical discovery phase trial in two diabetic subjects was performed in January 2015. Its main objective was to examine the short term metabolic impact of a single treatment with e-balance technology. Additional assays are pending. Analysis
LONDON, ENGLAND — (Marketwired) — 08/05/13 — Editors Note: There is a photo associated with this press release.Today, ToHealth Ltd is delighted to have reached the milestone of having delivered 50,000 NHS Health Checks.Rosie Cunningham Thomas, Chief Executive Officer of ToHealth, said: "Hitting 50,000 Health Checks marks a great milestone for ToHealth. We are delighted that our approach to Health Checks, focusing on delivering quality to patients and commissioners through our innovative
